dexamethasone sodium phosphate

Generic: dexamethasone sodium phosphate

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dexamethasone sodium phosphate
Generic Name dexamethasone sodium phosphate
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE
Active Ingredients

dexamethasone sodium phosphate 4 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1660
Product ID 51662-1660_19867cbe-bf77-94ae-e063-6294a90aa6b8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA084282
Listing Expiration 2026-12-31
Marketing Start 1975-07-15

Pharmacologic Class

Classes
corticosteroid hormone receptor agonists [moa] corticosteroid [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621660
Hyphenated Format 51662-1660

Supplemental Identifiers

RxCUI
1116927
UNII
AI9376Y64P

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dexamethasone sodium phosphate (source: ndc)
Generic Name dexamethasone sodium phosphate (source: ndc)
Application Number ANDA084282 (source: ndc)
Routes
INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE
source: ndc

Resolved Composition

Strengths
  • 4 mg/mL
source: ndc
Packaging
  • 10 POUCH in 1 CASE (51662-1660-3) / 1 VIAL in 1 POUCH (51662-1660-2) / 5 mL in 1 VIAL (51662-1660-1)
source: ndc

Packages (1)

51662-1660-3 10 POUCH in 1 CASE (51662-1660-3) / 1 VIAL in 1 POUCH (51662-1660-2) / 5 mL in 1 VIAL (51662-1660-1)

Ingredients (1)

dexamethasone sodium phosphate (4 mg/mL)

Linked Drug Pages (1)

DEXAMETHASONE SODIUM PHOSPHATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "INTRAVENOUS", "SOFT TISSUE"], "spl_id": "19867cbe-bf77-94ae-e063-6294a90aa6b8", "openfda": {"unii": ["AI9376Y64P"], "rxcui": ["1116927"], "spl_set_id": ["18a70010-6cc5-19e2-e063-6394a90a0ea6"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CASE (51662-1660-3)  / 1 VIAL in 1 POUCH (51662-1660-2)  / 5 mL in 1 VIAL (51662-1660-1)", "package_ndc": "51662-1660-3", "marketing_start_date": "19750715"}], "brand_name": "DEXAMETHASONE SODIUM PHOSPHATE", "product_id": "51662-1660_19867cbe-bf77-94ae-e063-6294a90aa6b8", "dosage_form": "INJECTION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "51662-1660", "generic_name": "DEXAMETHASONE SODIUM PHOSPHATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEXAMETHASONE SODIUM PHOSPHATE", "active_ingredients": [{"name": "DEXAMETHASONE SODIUM PHOSPHATE", "strength": "4 mg/mL"}], "application_number": "ANDA084282", "marketing_category": "ANDA", "marketing_start_date": "19750715", "listing_expiration_date": "20261231"}